Form 4 for PVLA PALVELLA THERAPEUTICS, INC.
Accepted 2026-03-20 00:00:00 ET · period of report 2026-03-18 · accession 0001104659-26-032695 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-20 | 2026-03-18 | PVLA | Goin Kathleen | COO | S - Sale+OE | $117.99 | -4,302 | 0 | -100% | -$507.6K |
| DM | 2026-03-20 | 2026-03-18 | PVLA | Goin Kathleen | COO | M - OptEx | $8.11 | +4,302 | 4,302 | New | +$34.9K |
| DM | 2026-03-20 | 2026-03-18 | PVLA | Goin Kathleen | COO | M - OptEx | $0.00 | -4,302 | 15.0K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-18 | S | D | 2,268 | $117.56 | 2,034 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.995 to $117.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. |
| 2 | Common | Common Stock | 2026-03-18 | M | A | 2,154 | $7.14 | 2,154 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-18 | M | A | 2,148 | $9.08 | 4,302 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-18 | S | D | 1,730 | $118.37 | 304 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.00 to $118.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. |
| 5 | Common | Common Stock | 2026-03-18 | S | D | 304 | $119.08 | 0 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $119.08 to $119.3767, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-03-18 | M | D | 2,154 | $0.00 | 15,089 | D | $7.14 · — to 2029-10-29 | 2,154 Common Stock | (F5) The stock option is fully vested. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-03-18 | M | D | 2,148 | $0.00 | 15,036 | D | $9.08 · — to 2030-10-14 | 2,148 Common Stock | (F5) The stock option is fully vested. |